Offer - Urjas Oil for just ₹ 1 X
Olmesar H 40 Tablet (15), a prescription drug, is manufactured in various forms such as Tablet. Olmesar H 40 Tablet (15) also has some secondary and off-label uses. These are listed below.
The optimal dosage of Olmesar H 40 Tablet (15) is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Common side effects of Olmesar H 40 Tablet (15) include Upper respiratory tract infection. Some other side effects of Olmesar H 40 Tablet (15) have been listed ahead. These side effects of Olmesar H 40 Tablet (15) are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Olmesar H 40 Tablet (15)'s effect is Severe during pregnancy and Mild for lactating mothers. Further, the section on Olmesar H 40 Tablet (15) related warnings talks about Olmesar H 40 Tablet (15)'s effects on the liver, heart and kidney.
Olmesar H 40 Tablet (15) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Asthma, Allergy, Kidney Disease are examples of such conditions. Other contraindications of Olmesar H 40 Tablet (15) have been discussed in the sections ahead.
Drug reaction of Olmesar H 40 Tablet (15) with other medicines has been reported. See below for a complete list.
You should also be aware that Olmesar H 40 Tablet (15) is not safe while driving, and is not addiction.
Olmesar H 40 Tablet (15) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olmesar H 40 Tablet (15) safe for pregnant women?
Olmesar H shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Olmesar H 40 Tablet (15) safe during breastfeeding?
Side effects of Olmesar H on breastfeeding women are very mild.
What is the effect of Olmesar H 40 Tablet (15) on the Kidneys?
Olmesar H has very mild side effects on the kidneys.
What is the effect of Olmesar H 40 Tablet (15) on the Liver?
Side effects of Olmesar H rarely affect the liver.
What is the effect of Olmesar H 40 Tablet (15) on the Heart?
Olmesar H has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Olmesar H 40 Tablet (15) unless your doctor advises you to do so -
Is this Olmesar H 40 Tablet (15) habit forming or addictive?
Olmesar H 40 Tablet (15) does not cause addiction.
Interaction between Food and Olmesar H 40 Tablet (15)
Some foods when eaten with Olmesar H 40 Tablet (15) can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Olmesar H 40 Tablet (15)
Consult your doctor before consuming alcohol while taking Olmesar H 40 Tablet (15) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173